RMC Pharmaceutical Solutions, Inc. Expands Its Global Expert CMC Services Team

RMC Pharmaceutical Solutions, Inc. enhances its global expert services team with the addition of Duane Bonam and Molly Sherrard as senior consultants.

Duane brings over 25 years of experience in bio-pharmaceutical process development, manufacturing support, and global CMC regulatory filings including marketing applications and post-approval changes. His expertise is with the development, scale-up and improvement of investigational and commercial manufacturing processes, process characterization, qualification and verification and QbD, viral clearance and safety issues; as well as authorship and technical review of CMC sections in regulatory filings. Before joining RMC, Duane was at Amgen for over 15 years. As a Scientific Director, he supported late-stage development and commercial processes, implementation of QbD, and participated in the FDA QbD pilot program. Prior to Amgen, Duane was at Wyeth (formerly Genetics Institute) where he helped develop the purification process for recombinant Factor IX and provided ongoing commercial life-cycle support. Duane received his Ph.D. in biochemistry from the University of Wisconsin, and a B.S in chemistry/biochemistry from the University of Illinois.

“As RMC’s global reputation for excellence continues to grow, Duane brings valuable strategic and tactical CMC experience to RMC,” said Timothy Joy, President of RMC. “Duane’s depth of experience in highly successful programs, lets him hit the ground running with practical, knowledgeable hands-on execution and assistance that our clients have come to expect from RMC. Several of our staff have worked with Duane in the past, and we’re confident that he will fit in well with RMC’s “Bolt On” strategy for CMC development for all kinds of pharmaceutical and biological products”

Molly comes to RMC with over…

Read the full article from the Source…

Back to Top